Subscribe to RSS
DOI: 10.1055/a-2767-6165
Universal submucosal dissection outperforms selective mucosal resection in early esophageal adenocarcinoma
Authors

Abstract
Background
In early esophageal adenocarcinoma (EAC), guidelines recommend endoscopic mucosal resection (EMR) for superficial (T1a) lesions and endoscopic submucosal dissection (ESD) for deeper (T1b) lesions based on visual assessment. We evaluated the outcomes of this targeted resection strategy.
Methods
In a retrospective bicentric study (2009–2023), 311 T1 EACs (235 T1a, 76 T1b) underwent endoscopic resection: EMR for presumed T1a and ESD for suspected T1b lesions. The primary outcome was complete (R0) resection stratified by tumor stage and resection technique. Secondary outcomes were rates of curative resection, adverse events, and surgery.
Results
EMR was appropriately applied in 63.0% of T1a cases, and ESD was correctly selected in 60.5% of T1b cases. R0 resection rates were higher with ESD than with EMR for both stages: T1a, 92.9% vs. 80.4%; T1b, 63.0% vs. 26.7%. Curative resection (ESD 60.9% vs. EMR 67.4%), surgery (19.5% vs. 14.0%), and adverse events (7.5% vs. 10.1%) were comparable. On multivariable analysis, ESD was the only independent predictor of complete resection. If surgery decisions had been based on R0 rather than curative outcomes, 20% of post-EMR and 50% of post-ESD esophagectomies could have been avoided
Conclusions
Endoscopic staging of early EAC is imperfect, leading to frequent mismatch between chosen and optimal resection techniques. ESD achieved higher complete resection rates for both T1a and T1b cancers without increased morbidity. ESD may therefore represent the preferred strategy for early EAC, potentially reducing unnecessary surgery.
Publication History
Received: 22 May 2025
Accepted after revision: 06 November 2025
Article published online:
13 January 2026
© 2026. Thieme. All rights reserved.
Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
-
References
- 1 Lander S, Lander E, Gibson MK. Esophageal cancer: overview, risk factors, and reasons for the rise. Curr Gastroenterol Rep 2023; 25: 275-279
- 2 Rubenstein JH, Sawas T, Wani S. et al. AGA clinical practice guideline on endoscopic eradication therapy of Barrett’s esophagus and related neoplasia. Gastroenterology 2024; 166: 1020-1055
- 3 di Pietro M, Trudgill NJ, Vasileiou M. et al. National Institute for Health and Care Excellence (NICE) guidance on monitoring and management of Barrett’s oesophagus and stage I oesophageal adenocarcinoma. Gut 2024; 73: 897-909
- 4 Forbes N, Elhanafi SE, Al-Haddad MA. et al. American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: summary and recommendations. Gastrointest Endosc 2023; 98: 271-284
- 5 Al-Haddad MA, Elhanafi SE, Forbes N. et al. American Society for Gastrointestinal Endoscopy guideline on endoscopic submucosal dissection for the management of early esophageal and gastric cancers: methodology and review of evidence. Gastrointest Endosc 2023; 98: 285-305 e38
- 6 Pimentel-Nunes P, Libânio D, Bastiaansen BAJ. et al. Endoscopic submucosal dissection for superficial gastrointestinal lesions: European Society of Gastrointestinal Endoscopy (ESGE) Guideline – update 2022. Endoscopy 2022; 54: 591-622
- 7 Sharma P, Shaheen NJ, Katzka D. et al. AGA clinical practice update on endoscopic treatment of Barrett’s esophagus with dysplasia and/or early cancer: expert review. Gastroenterology 2020; 158: 760-769
- 8 Weusten B, Bisschops R, Coron E. et al. Endoscopic management of Barrett’s esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Position Statement. Endoscopy 2017; 49: 191-198
- 9 Gotink AW, van de Ven SEM, Ten Kate FJ. et al. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study. Endoscopy 2022; 54: 109-117
- 10 Cotton PB, Eisen GM, Aabakken L. et al. A lexicon for endoscopic adverse events: report of an ASGE workshop. Gastrointest Endosc 2010; 71: 446-454
- 11 Nass KJ, Zwager LW, van der Vlugt M. et al. Novel classification for adverse events in GI endoscopy: the AGREE classification. Gastrointest Endosc 2022; 95: 1078-1085 e8
- 12 Krause J, Rösch T, Steurer S. et al. Quantitative analysis of submucosal excision depth in endoscopic resection for early Barrett’s cancer. Endoscopy 2022; 54: 565-570
- 13 Weusten B, Bisschops R, Dinis-Ribeiro M. et al. Diagnosis and management of Barrett esophagus: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2023; 55: 1124-1146
- 14 Radadiya D, Desai M, Patel H. et al. Endoscopic submucosal dissection and endoscopic mucosal resection for Barrett’s-associated neoplasia: a systematic review and meta-analysis of the published literature. Endoscopy 2024; 56: 940-954
- 15 Terheggen G, Horn EM, Vieth M. et al. A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett’s neoplasia. Gut 2017; 66: 783-793
- 16 Fujiyoshi Y, Khalaf K, Tham D. et al. Recurrence following successful eradication of neoplasia with endoscopic mucosal resection compared with endoscopic submucosal dissection in Barrett’s esophagus: a retrospective comparison. Endoscopy 2025; 57: 5-13
- 17 Mejia Perez LK, Yang D, Draganov PV. et al. Endoscopic submucosal dissection vs. endoscopic mucosal resection for early Barrett’s neoplasia in the West: a retrospective study. Endoscopy 2022; 54: 439-446
- 18 Vantanasiri K, Joseph A, Sachdeva K. et al. Rates of recurrent intestinal metaplasia and dysplasia after successful endoscopic therapy of Barrett’s neoplasia by endoscopic mucosal resection vs endoscopic submucosal dissection and ablation: a large North American multicenter cohort. Am J Gastroenterol 2024; 119: 1831-1840
- 19 Doumbe-Mandengue P, Pellat A, Belle A. et al. Endoscopic submucosal dissection versus endoscopic mucosal resection for early esophageal adenocarcinoma. Clin Res Hepatol Gastroenterol 2023; 47: 102138
- 20 Codipilly DC, Dhaliwal L, Oberoi M. et al. Comparative outcomes of cap assisted endoscopic resection and endoscopic submucosal dissection in dysplastic Barrett’s esophagus. Clin Gastroenterol Hepatol 2022; 20: 65-73 e1
- 21 Podboy A, Kolahi KS, Friedland S. et al. Endoscopic submucosal dissection is associated with less pathologic uncertainty than endoscopic mucosal resection in diagnosing and staging Barrett’s-related neoplasia. Dig Endosc 2020; 32: 346-354
- 22 Yang D, Othman M, Draganov PV. Endoscopic mucosal resection vs endoscopic submucosal dissection for Barrett’s esophagus and colorectal neoplasia. Clin Gastroenterol Hepatol 2019; 17: 1019-1028
- 23 Han C, Sun Y. Efficacy and safety of endoscopic submucosal dissection versus endoscopic mucosal resection for superficial esophageal carcinoma: a systematic review and meta-analysis. Dis Esophagus 2021; 34: doaa081
- 24 Yang D, Zou F, Xiong S. et al. Endoscopic submucosal dissection for early Barrett’s neoplasia: a meta-analysis. Gastrointest Endosc 2018; 87: 1383-1393
- 25 Park CH, Kim EH, Kim HY. et al. Clinical outcomes of endoscopic submucosal dissection for early stage esophagogastric junction cancer: a systematic review and meta-analysis. Dig Liver Dis 2015; 47: 37-44
- 26 Younis F, Rösch T, Beyna T. et al. Expert assessment of infiltration depth and recommendation of endoscopic resection technique in early Barrett cancer. United European Gastroenterol J 2024; 12: 848-858
- 27 Gupta S, Mandarino FV, Shahidi N. et al. Can optical evaluation distinguish between T1a and T1b esophageal adenocarcinoma: an international expert interobserver agreement study. Endoscopy 2025; 57: 200-207
- 28 Gotoda T, Yanagisawa A, Sasako M. et al. Incidence of lymph node metastasis from early gastric cancer: estimation with a large number of cases at two large centers. Gastric Cancer 2000; 3: 219-225
- 29 Chan MW, Nieuwenhuis E, Jansen M. et al. Low recurrence rate after endoscopic resection (R0) of high-risk T1 adenocarcinoma in Barrett’s esophagus support a strict endoscopic surveillance strategy: preliminary results of a prospective, international, multicenter cohort study (PREFER). Gastrointest Endosc 2024; 99: AB997
- 30 Holleran TJ, Napolitano MA, Sparks AD. et al. Hospital operative volume and esophagectomy outcomes in the Veterans Affairs system. J Surg Res 2022; 275: 291-299
- 31 Wang Q, Mine S, Nasu M. et al. Association of hospital volume and long-term survival after esophagectomy: a systematic review and meta-analysis. Front Surg 2023; 10: 1161938
- 32 Baum P, Diers J, Lichthardt S. et al. Mortality and complications following visceral surgery: a nationwide analysis based on the diagnostic categories used in German hospital invoicing data. Dtsch Arztebl Int 2019; 116: 739-746
- 33 Duprée A, Ehlken H, Rösch T. et al. Laparoscopic lymph node sampling: a new concept for patients with high-risk early esophagogastric junction cancer resected endoscopically. Gastrointest Endosc 2021; 94: 282-290
- 34 Casas MA, Angeramo CA, Bras Harriott C. et al. Surgical outcomes after totally minimally invasive Ivor Lewis esophagectomy. A systematic review and meta-analysis. Eur J Surg Oncol 2022; 48: 473-481
- 35 Sakamoto T, Fujiogi M, Matsui H. et al. Comparing perioperative mortality and morbidity of minimally invasive esophagectomy versus open esophagectomy for esophageal cancer: a nationwide retrospective analysis. Ann Surg 2021; 274: 324-330
- 36 van den Boorn HG, Stroes CI, Zwinderman AH. et al. Health-related quality of life in curatively-treated patients with esophageal or gastric cancer: a systematic review and meta-analysis. Crit Rev Oncol Hematol 2020; 154: 103069
- 37 Kitagawa Y, Kitajima M. Lymphatic mapping for upper gastrointestinal malignancies. Semin Oncol 2004; 31: 409-414
- 38 Nihei K, Minashi K, Yano T. et al. Final analysis of diagnostic endoscopic resection followed by selective chemoradiotherapy for stage I esophageal cancer: JCOG0508. Gastroenterology 2023; 164: 296-299 e2
- 39 Yoshio T, Minashi K, Mizusawa J. et al. Effect of chemoradiation on the development of second primary cancers after endoscopic resection of T1 esophageal squamous cell carcinoma. Esophagus 2022; 19: 469-476
- 40 Takahashi S, Hatta W, Watanabe K. et al. Prognostic benefit of additional treatment after endoscopic submucosal dissection for esophageal squamous cell carcinoma. Dig Dis Sci 2023; 68: 2050-2060
- 41 Naito S, Yoshio T, Ishiyama A. et al. Long-term outcomes of esophageal squamous cell carcinoma with invasion depth of pathological T1a-muscularis mucosae and T1b-submucosa by endoscopic resection followed by appropriate additional treatment. Dig Endosc 2022; 34: 793-804
- 42 Minashi K, Nihei K, Mizusawa J. et al. Efficacy of endoscopic resection and selective chemoradiotherapy for stage I esophageal squamous cell carcinoma. Gastroenterology 2019; 157: 382-390 e3
- 43 Wang J, Zhang X, Gan T. et al. Risk factors and a predictive nomogram for lymph node metastasis in superficial esophageal squamous cell carcinoma. World J Gastroenterol 2023; 29: 6138-6147
- 44 van Munster SN, Verheij EPD, Ozdemir Ö. et al. Incidence and prediction of unrelated mortality after successful endoscopic eradication therapy for Barrett’s neoplasia. Gastroenterology 2024; 166: 1058-1068
- 45 Gallegos MMM, Gomes ILC, Brunaldi VO. et al. Endoscopic submucosal dissection vs. endoscopic mucosal resection in the treatment of early Barrett’s neoplasia: systematic review and meta-analysis. Dig Endosc 2024; 36: 1299-1311
- 46 Ell C, May A, Gossner L. et al. Endoscopic mucosal resection of early cancer and high-grade dysplasia in Barrett’s esophagus. Gastroenterology 2000; 118: 670-677
- 47 Manner H, May A, Pech O. et al. Early Barrett’s carcinoma with “low-risk” submucosal invasion: long-term results of endoscopic resection with a curative intent. Am J Gastroenterol 2008; 103: 2589-2597
- 48 Pech O, Bollschweiler E, Manner H. et al. Comparison between endoscopic and surgical resection of mucosal esophageal adenocarcinoma in Barrett’s esophagus at two high-volume centers. Ann Surg 2011; 254: 67-72
- 49 Yang D, King W, Aihara H. et al. Effect of endoscopic submucosal dissection on histologic diagnosis in Barrett’s esophagus visible neoplasia. Gastrointest Endosc 2022; 95: 626-633
- 50 Marginean EC, Dhanpat J. Pathologic assessment of endoscopic resection specimens with superficial carcinoma of the esophagus: current practice and practical issues. Ann N Y Acad Sci 2020; 1482: 130-145
- 51 Martelli MG, Duckworth LV, Draganov PV. Endoscopic submucosal dissection is superior to endoscopic mucosal resection for histologic evaluation of Barrett’s esophagus and Barrett’s-related neoplasia. Am J Gastroenterol 2016; 111: 902-903
- 52 van Tilburg L, Verheij EPD, van de Ven SEM. et al. Vertical tumor-positive resection margins and the risk of residual neoplasia after endoscopic resection of Barrett’s neoplasia: a nationwide cohort with pathology reassessment. Endoscopy 2024; 56: 559-568
